@article{638183d016ea4ae69400699d322ef608,
title = "Barriers to treatment access for chronic hepatitis C virus infection: A case series",
abstract = "Restrictive policies on access to new, curative hepatitis C treatments represent a substantial barrier to treating patients infected with hepatitis C. This case series demonstrates challenges experienced by patients and practitioners in accessing these treatments and highlights several strategies for navigating the treatment preauthorization process.",
keywords = "HCV, Hepatitis C virus, Insurance, Treatment",
author = "Millman, {Alexander J.} and Boatemaa Ntiri-Reid and Risha Irvin and Kaufmann, {Maggie H.} and Andrew Aronsohn and Duchin, {Jeffrey S.} and Scott, {John D.} and Claudia Vellozzi",
note = "Funding Information: Funding/Support: This work was supported by the Centers for Disease Control and Prevention (CDC) Funding Opportunity Announcement PS14-1413, Community-based Test and Cure of Hepatitis C. Publisher Copyright: {\textcopyright} 2017, IAS–USA. All rights reserved.",
year = "2017",
language = "English (US)",
volume = "25",
pages = "110--113",
journal = "Topics in Antiviral Medicine",
issn = "2161-5861",
publisher = "International Antiviral Society",
number = "3",
}